European Centre for Disease Prevention and Control, Stockholm, Sweden.
Euro Surveill. 2014 Oct 16;19(41):20928. doi: 10.2807/1560-7917.es2014.19.41.20928.
Following the European Union (EU) Council Recommendation on prudent use of antimicrobial agents in human medicine in 2001, and the success of national campaigns, i.e. Belgium and France, the European Centre for Disease Prevention and Control (ECDC) decided to establish the European Antibiotic Awareness Day (EAAD) on 18 November as platform to support national campaigns across Europe. This article provides an overview of EAAD tools, materials, and activities developed during the first five years. It shows that EAAD has been successful due to good cooperation between ECDC and national institutions, strong political and stakeholder support and evidence-based development of campaign materials. EAAD has provided a platform for pre-existing national campaigns and encouraged similar campaigns to develop where neither political support had been secured, nor financial support had been available. As a result, participating countries have continuously expressed strong support for ECDC to continue its work on EAAD. This has been endorsed by a steadily increasing number of countries participating and the growing interest of varied professional and stakeholder organisations. We conclude that EAAD should continue to act as catalyst for discussion and as mechanism to raise awareness of the public and prescribers about prudent use of antibiotics.
继 2001 年欧盟理事会(EU)关于在人用医学中谨慎使用抗菌药物的建议,以及国家运动取得成功(例如比利时和法国)之后,欧洲疾病预防控制中心(ECDC)决定于 11 月 18 日设立欧洲抗菌药物认识日(EAAD),作为在整个欧洲支持国家运动的平台。本文概述了在最初五年中开发的 EAAD 工具、材料和活动。结果表明,由于 ECDC 与国家机构之间的良好合作、强有力的政治和利益攸关方的支持以及基于证据的宣传材料的开发,EAAD 取得了成功。EAAD 为现有的国家运动提供了一个平台,并鼓励在没有政治支持或财务支持的情况下制定类似的运动。因此,参与国不断表示强烈支持 ECDC 继续开展 EAAD 工作。这一点得到了越来越多参与国的认可,以及各种专业和利益攸关方组织的兴趣不断增加。我们的结论是,EAAD 应继续作为讨论的催化剂,并作为提高公众和处方者对抗生素谨慎使用意识的机制。